What we know about: The new mpox outbreak as EU agency says more Europe cases ‘highly likely’

Hello and welcome to the details of What we know about: The new mpox outbreak as EU agency says more Europe cases ‘highly likely’ and now with the details

Nevin Al Sukari - Sana'a - PARIS, Aug 17 — A surging mpox outbreak in Africa was declared an emergency by the World Health Organisation this week and the European Centre for Disease Prevention and Control (ECDC), an EU agency, yesterday said more imported cases to Europe were “highly likely”.

The Africa Centres for Disease Control and Prevention (Africa CDC) declared its first-ever Public Health Emergency of Continental Security (PHECS) for the deadly disease.

It is the second time the WHO has issued its public health emergency warning since the epidemic first spread around the world in 2022.

Now the virus has crossed from its epicentre in the Democratic Republic of Congo to other African nations and was detected this week for the first time in Sweden and Pakistan.

What is mpox?

The disease, formerly known as monkeypox, was first detected in humans in the DRC in 1970.

There are two subtypes of the virus: clade 1 and clade 2.

The deadlier clade 1 has been endemic in the Congo Basin in central Africa for decades.

The less severe clade 2 has become endemic in parts of West Africa.

Mpox can spread human-to-human through sexual or close physical contact. Symptoms include fever, muscular aches and large boil-like skin lesions.

The virus gained international prominence in May 2022, when a less deadly strain called clade 2b spread around the world, mostly affecting gay and bisexual men.

Between January 2022 and June 2024, 208 deaths and more than 99,000 mpox cases were recorded across 116 countries, according to the WHO.

An undated colourised scanning electron micrograph of mpox virus (red) on the surface of infected VERO E6 cells (green), captured at the National Institute of Allergy and Infectious Diseases (NIAID) Integrated Research Facility (IRF) in Fort Detrick, Maryland.

An undated colourised scanning electron micrograph of mpox virus (red) on the surface of infected VERO E6 cells (green), captured at the National Institute of Allergy and Infectious Diseases (NIAID) Integrated Research Facility (IRF) in Fort Detrick, Maryland.

What is new?

The latest surge has been of the deadlier clade 1 — and its new mutated variant.

The new strain, called clade 1b, was first detected among sex workers in the DRC in September 2023.

Sweden this week reported the first case of the variant outside of Africa, and the EU’s health body urged countries to increase preparedness. Pakistan reported Asia’s first case.

“It is not surprising... that travel between continents has brought this case to Europe,” said Brian Ferguson, an Associate Professor of Immunology, University of Cambridge.

He added that cases were likely to spike in Europe and elsewhere as “there are currently no mechanisms in place to stop imported cases of mpox”.

Containing the epidemic will require “rapid international co-operation”, said Francois Balloux of the University College of London Genetics Institute—adding there was “no evidence of transmission in Europe at this stage”.

Dr Tresor Wakilongo verifies the evolution of skin lesions on the ear of Innocent, suffering from Mpox — an infectious disease caused by the monkeypox virus that sparks off a painful rash, enlarged lymph nodes and fever; at the treatment centre in Munigi, following Mpox cases in Nyiragongo territory near Goma, North Kivu province, Democratic Republic of Congo July 19, 2024. — Reuters pic

Dr Tresor Wakilongo verifies the evolution of skin lesions on the ear of Innocent, suffering from Mpox — an infectious disease caused by the monkeypox virus that sparks off a painful rash, enlarged lymph nodes and fever; at the treatment centre in Munigi, following Mpox cases in Nyiragongo territory near Goma, North Kivu province, Democratic Republic of Congo July 19, 2024. — Reuters pic

Who is affected?

Clade 1 mpox is “known for causing more severe disease in young children, pregnant women, and immunocompromised people”, said Jonas Albarnaz, who specialises in pox viruses at the Pirbright Institute in Britain.

Clade 1b is driven by sexual transmission and mostly infects young adults, Albarnaz said.

It has also been recorded spreading through non-sexual contact between people, including children playing together at school.

Clade 1b causes death in around 3.6 per cent of cases, though infants and children are more at risk, according to the WHO.

Christian Musema, a laboratory nurse, takes a sample from a child declared a suspected case of Mpox at the treatment centre in Munigi, following Mpox cases in Nyiragongo territory near Goma, North Kivu province, Democratic Republic of the Congo July 19, 2024. — Reuters pic

Christian Musema, a laboratory nurse, takes a sample from a child declared a suspected case of Mpox at the treatment centre in Munigi, following Mpox cases in Nyiragongo territory near Goma, North Kivu province, Democratic Republic of the Congo July 19, 2024. — Reuters pic

Where is affected?

More mpox cases were reported in the first half of this year than in all of 2023, according to WHO figures.

The majority of recent cases have been in the DRC, where 548 people have died so far this year, the government said.

Over the last month, previously unaffected countries such as Burundi, Kenya, Rwanda and Uganda have reported outbreaks, according to the Africa CDC. None have reported deaths, the WHO said.

Nigeria has flagged 39 cases of a milder strain of mpox this year, health officials said Friday.

Sweden and Pakistan this week reported the first mpox cases outside of Africa, with the WHO warning more cases of the new strain were likely in Europe.

This file photo taken on August 9, 2022 shows vials of the Jynneos Monkeypox vaccine are prepared at a pop-up vaccination clinic in Los Angeles, California. — AFP pic

This file photo taken on August 9, 2022 shows vials of the Jynneos Monkeypox vaccine are prepared at a pop-up vaccination clinic in Los Angeles, California. — AFP pic

Is there a vaccine?

During mpox’s global spread in 2022, vaccines were deployed in Europe and North America which helped control the outbreak.

But vaccines have not been made widely available in the African countries most affected by mpox.

The US Department of Health said Wednesday it would donate 50,000 doses of an mpox vaccine to DRC.

On Tuesday, Africa CDC head Jean Kaseya announced an agreement with the European Union and Danish drugmaker Bavarian Nordic to distribute 200,000 doses across the continent.

Although that would not be enough, Africa could secure another 10 million vaccines, Kaseya told a media briefing.

Bavarian Nordic said yesterday it was seeking European approval to use its mpox vaccine in children aged 12 to 17. — AFP

These were the details of the news What we know about: The new mpox outbreak as EU agency says more Europe cases ‘highly likely’ for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Sentencing phase begins in French mass rape trial that shook the nation
NEXT China grapples with rise in violent attacks, zeroes in on ‘common’ disputes to restore public security

Author Information

I have been an independent financial adviser for over 11 years in the city and in recent years turned my experience in finance and passion for journalism into a full time role. I perform analysis of Companies and publicize valuable information for shareholder community. Address: 2077 Sharon Lane Mishawaka, IN 46544, USA Phone: (+1) 574-255-1083 Email: [email protected]